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Abstract
Purpose Currently, most centres use 2-D planar
lymphoscintigraphy when performing dynamic sentinel lymph
node biopsy in penile cancer patients with clinically impalpable
inguinal nodes. This study aimed to investigate the role of
SPECT/CT following 2-D planar lymphoscintigraphy (dynam-
ic and static) in the detection and localization of sentinel lymph
nodes in the groin.
Methods A qualitative (visual) review was performed on pla-
nar followed by SPECT/CT lymphoscintigraphy in 115 con-
secutive patients (age 28–86 years) who underwent injection of
99mTc-nanocolloid followed by immediate acquisition of dy-
namic (20 min) and early static scans (5 min) initially and
further delayed static (5 min) images at 120 min followed by
SPECT/CT imaging. The lymph nodes detected in each groin
on planar lymphoscintigraphy and SPECT/CTwere compared.
Results A total of 440 and 467 nodes were identified on planar
scintigraphy and SPECT/CT, respectively. Overall, SPECT/CT
confirmed the findings of planar imaging in 28/115 cases
(24%). In the remaining 87 cases (76%), gross discrepancies
were observed between planar and SPECT/CT images.
SPECT/CT identified 17 instances of skin contamination (16
patients, 13%) and 36 instances of in-transit lymphatic tract
activity (24 patients, 20%) that had been interpreted as tracer-
avid lymph nodes on planar imaging. In addition, SPECT/CT
identified 53 tracer-avid nodes in 48 patients (42%) that were
not visualized on planar imaging and led to reclassification of
the drainage basins (pelvic/inguinal) of 27 tracer-avid nodes.
Conclusions The addition of SPECT/CT improved the rate of
detection of true tracer-avid lymph nodes and delineated their
precise (3-D) anatomic localization in drainage basins.
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Introduction
Penile cancer is a rare malignancy in Western Europe and
North America. In England, the incidence has increased by
approximately 20% over the last 40 years [1], and there are
now just over 500 cases annually in the United Kingdom.
Penile cancer has a characteristic stepwise lymphatic dissem-
ination pattern, first to the inguinal lymph nodes and then to
the pelvic lymph nodes. Haematogenous spread usually oc-
curs in advanced stages of disease [2].
The single most important prognostic indicator is the pres-
ence of metastatic disease in the inguinal lymph nodes.
Metastatic disease in a single inguinal lymph node is associ-
ated with a 5-year survival rate of over 80%. However, if the
number of metastatic inguinal lymph nodes exceeds two, the
5-year survival rate is reduced to 40% [3]. Since only 15–20%
of clinically impalpable inguinal nodes (cN0) harbour meta-
static disease, performing a radical inguinal lymphadenecto-
my in all of these patients would result in a high risk of over-
treatment [4]. The concept of sentinel lymph node biopsy
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(SNB) was first coined by Cabanas in 1977 [5], labelling the
first lymph node receiving the lymphatic drainage from the
primary neoplastic site as the Bsentinel lymph node^, and in
the presence of lymphatic spread, this would be the first lymph
node to host the metastatic disease. The original study by
Cabanas used the superficial epigastric vein as an anatomical
landmark, with the sentinel node always medial to this vein.
However, the incorporation of dynamic studies by Horenblas
et al. followed by correlation with SPECT/CT confirmed the
individual variability in the drainage pattern of each tumour,
indicating that the sentinel node could be located outside the
superomedial zone [6]. Since that time, the concept of sentinel
lymph node biopsy has been evaluated, accepted, and
established in many clinical pathways [7]. Its application in
penile cancer was first highlighted by a group at the
Netherlands Cancer Institute in the 1990s, followed by several
other groups [8–10]. The approach has offered a minimally
invasive technique for identification of micro-metastases in
patients with cN0 disease, thus reducing the need for radical
inguinal lymphadenectomy.
The superiority of single-photon emission computed tomog-
raphy (SPECT) and hybrid SPECT/CT technology over planar
nuclear imaging has been demonstrated in a number of benign
and malignant disease processes [11–15]. Despite this, there is
still uncertainty with regard to the use and benefits of SPECT/
CT in penile cancer. The aim of this study was to prospectively
compare the use of conventional planar lymphoscintigraphy
with SPECT/CT in patients undergoing preoperative imaging
prior to dynamic sentinel lymph node biopsy.
Materials and methods
A tota l o f 115 pa t i en t s underwent bo th p lanar
lymphoscintigraphy and SPECT/CT, and the data sets were
analysed visually to identify discrepancies in nodal detection
between these imaging modalities. Nodes were classified as
belonging to the left or right side and were localized to the
inguinal or pelvic basin.
SPECT/CT was performed after conventional planar
lymphoscintigraphy in order to establish whether this imaging
modality identified additional lymph nodes, allowed better
delineation of the position of the sentinel lymph nodes relative
to adjacent structures, detected lymphatic channels falsely
identified as the sentinel lymph node, and allowed assessment
of mis-localization secondary to scatter. In addition, we ex-
plored whether any inadvertent radioactive contamination was
detected by SPECT/CTwhile being either missed completely
or identified as a positive lymph node on planar imaging.
Study period
The study period was June 2011 to December 2015.
Patient population
One hundred and nineteen (119) consecutive patients were
included in the study; however, four patients were excluded,
in two cases because of a mechanical defect in SPECT/CTand
in two further cases owing to a delay in the SPECT/CT acqui-
sition, as a result of which the SPECT/CTwas not completed.
Therefore, the final population for data analysis comprised
115 patients (all adults; age range 28–86; median age
56 years). The institutional review board approved the proto-
col as a standard of care and all patients were accepted for
inclusion, as they had already undergone surgery for the pri-
mary lesion and had confirmed penile squamous cell carcino-
ma (stage ≥ T1G2) and cN0 disease.
Patient preparation and administration
of radiopharmaceutical
Patients attended the nuclear medicine department following
application of local anaesthetic (EMLA®) to the area proximal
to the site of tumour excision. Approximately 30 MBq of
technetium-99 m nanocolloid (range 20–40 MBq) in 0.4 ml
was injected intradermally just proximal to the surgical scar at
four points, giving an effective radiation dose of between 0.35
and 0.45 mSv.
Image sequence, acquisition techniques, and parameters
All images were acquired on a hybrid SPECT/CT system: a
dual-head Infinia Hawkeye 4, Model H3000WL (General
Electric Medical Systems, Milwaukee, WI, USA). The acqui-
sitions were carried out using a low-energy high-resolution
(LEHR) collimator with zoom of x1 and keeping the energy
window(s) to 140 keV, 20% width, and 3% offset.
A strict image sequence was followed in all cases. The
dynamic anterior acquisition was performed immediately after
the radiotracer injection with dual-head projections of 120x10
s, 128x128 matrix, 180°/detector for a total of 20 min. This
was immediately followed by a 5-min early static anterior
image acquisition from the top of the thighs to the lower ab-
domen. After an interval of 2 h post-injection, the patient
underwent a further 5-min static anterior (delayed) image ac-
quisition, again from the top of the thighs to the lower abdo-
men. This was immediately followed by SPECT/CT acquisi-
tions with a standard low-dose CT protocol of 140 kVp,
2.5 mA, 14-s rotations, and the full 40-cm scan range, cover-
ing an identical field of view to planar imaging.
Data reconstruction, display and reporting, and probe
localization
The reconstruction and display was performed on a GE
Xeleris workstation. The displayed image data were
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Belectronically windowed^ at the console to highlight the sen-
tinel node(s) and drainage path(s). Both SPECT images and
computed tomography images were matched and then recon-
structed using GE Volumetric MI Evolution software. The
images were reviewed by duty nuclear physicians, confirming
the position of the sentinel node(s) before the skin was marked
using a cobalt-57 pencil. The principle of detecting the first
node seen on the dynamic images showing radioisotope up-
take was followed in order to isolate the sentinel node, and
was confirmed by early static image. In cases of non-
visualized dynamic and early static images, the most intense
tracer-avid inguinal basin node (on delayed static and SPECT/
CT images) was perceived and called the sentinel node, and
the others were highlighted as echelon nodes. The final
screenshot images were generated for our urology colleagues,
demonstrating the sentinel and echelon nodes with depth es-
timation (Fig. 1). Intraoperatively, all of the avid nodes were
probe-localized, and these inguinal nodes were surgically ex-
cised for pathological analysis.
Data analysis
As our study primarily focused on visual assessment of the
images, the data were analysed qualitatively in two phases.
During the first phase of image analysis, early and delayed
static planar lymphoscintigraphy images were reviewed to
determine the total number of visualized tracer-avid nodes,
along with their localization to the inguinal and pelvic basins.
The second phase involved comparing the delayed static im-
ages with SPECT/CT images.
We performed a detailed visual (qualitative) analysis in
which the two data sets (2-D planar vs 3-D SPECT/CT) were
compared by two senior nuclear physicians (JB and ZS). If
there was no discrepancy between the delayed static and
SPECT/CT images, the value of additional SPECT/CT was
classified as insignificant or just confirmatory. On the other
hand, if there were discrepancies—for example, with respect
to nodal yield (increased or decreased number of tracer-avid
nodes), anatomic localization of nodes to the designated in-
guinal and pelvic basins, retention of focal tracer activity in
lymphatic tracts, or true nodal activity and other focal tracer-
avid spots (e.g., contaminations)—then the value of SPECT/
CTwas classified as significant.
Statistical analysis
Although we reported our results descriptively, we also per-
formed McNemar’s test (PASW Statistics for Windows, ver-
sion 18.0; SPSS Inc., Chicago, IL, 2009) using a continuity
correction to evaluate the null hypothesis that the two modal-
ities are equally good at detecting tracer-avid lymph nodes.
The level of statistical significance was set at p = 0.05.
Results
A total of 440 avid nodes were identified on delayed planar
scintigraphy, with 234 on the right side and 206 on the left, of
which 357 were perceived to be located in the inguinal basin
and 83 located within the pelvis. A total of 467 avid nodes
were identified on SPECT/CT images, with 253 on the right
side and 214 on the left, of which 355 were noted to be located
in the inguinal basin and 112 nodes in the pelvis (Table 1).
Overall, SPECT/CT confirmed the findings of planar im-
aging in 28/115 cases (24%), and a total of 387 nodes were
identified by both modalities (Table 2). In the aforementioned
28 patients, there was a perfect nodal match between planar
and SPECT/CT images. In the remaining 87 cases (76%),
gross discrepancies between planar and SPECT/CT images
Fig. 1 Generated image for urology colleagues to facilitate intraoperative
sentinel node localization
Table 1 Number of nodes identified using planar lymphoscintigraphy vs SPECT/CT and nodal distribution in the inguinal and pelvic basins and the
right and left groin
No. of nodes Total Right groin Left groin Inguinal basin Pelvic basin
Planar SPECT/CT Planar SPECT/CT Planar SPECT/CT Planar SPECT/CT Planar SPECT/CT
Total 440 467 234 253 206 214 357 355 83 112
Average per patient 3.83 3.92 2.03 2.2 1.79 1.86 3.1 3.09 0.72 0.97
Standard deviation 2 1.93 1.36 1.36 1.34 1.24 1.79 1.48 0.93 0.92
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were observed with regard to the number of identified tracer-
avid nodes, localization of nodes to the inguinal or pelvic
drainage basin, retention of activity in lymphatic tracts, and
contaminations resembling tracer-avid nodes.
In the 76% of patients in whom gross discrepancies were
observed between planar and SPECT/CT images, SPECT/CT
identified 17 instances of skin contamination in 16 patients
(13%) (Fig. 2a, b) and delineated 36 instances of in-transit
lymphatic tract activity (Fig. 3a, b) in 24 patients (20%).
These 53 cases were considered to represent tracer-avid lymph
nodes on planar imaging and hence contributed to a signifi-
cant false-positive rate. Furthermore, SPECT/CT led to a re-
classification of 27 tracer-avid nodes (in nearly 20% of pa-
tients) from the inguinal basin to the pelvis or vice versa. In
addition, 21 tracer-avid nodes in the inguinal basin and 32
tracer-avid nodes in the pelvis that were identified in 48 pa-
tients (42%) on SPECT/CT images were not visualized on
conventional 2-D planar scintigraphy.
Although the difference in the absolute number of nodes
between the two modalities was small when the images were
analysed individually, in real-time clinical practice, the rela-
tive difference was substantial, as shown by the contingency
matrix in Table 2. This was also demonstrated on McNemar’s
test, which revealed statistically significant differences in node
detection between planar scintigraphy and SPECT/CT, veri-
fying the superiority of SPECT/CT in lymph node identifica-
tion (two-tailed p = 0.024).
In the clinical scenario, bilateral inguinal nodes should
be detected, reflecting the lymphatic drainage of the pe-
nis, unless surgery in the form of an inguinal lymphade-
nectomy has already been performed, in which case uni-
lateral visualization is expected. In our cohort, unilateral
drainage was found in 26 patients and bilateral drainage
in the remaining 89 patients. In addition, it was observed
that dynamic and early static images demonstrated tracer
progression to a node (true sentinel node by definition) in
97 cases (84%). Furthermore, there were 18 cases (16%)
where dynamic and early static images did not show nodal
visualization in either groin. Tracer-avid nodes, however,
were visualized in 112 cases (97%) at the end of the
delayed static images at 120 min.
SPECT/CT images, on the other hand, showed at least one
tracer-avid node in the inguinal basins either unilaterally or
bilaterally in all 115 cases. Of the three cases which did not
show tracer-avid nodes following delayed static images,
SPECT/CT identified four inguinal basins with a cumulative
nine nodes. More importantly, two of these additional four
basins contained metastatic nodes.
Discussion
Cross-sectional imaging such as X-ray computed tomography
(CT) or magnetic resonance imaging (MRI) can detail struc-
tural changes, but is unable to supply precise information on
the functional status of pathological lesions. On the other
hand, scintigraphy yields functional data sets defining bio-
chemical and metabolic changes, but suffers from the draw-
back that it is often difficult to precisely define the extent of
disease, owing to the lack of anatomic definition. However,
the co-registered images provided by hybrid SPECT/CT offer
significant gains in observer confidence, surgical precision,
and diagnostic accuracy [16].
Since the publication of penile cancer guidelines by the
European Association of Urology (EAU) in 2001–2002
[17], the standard protocols have not acknowledged the rou-
tine use of SPECT/CT in sentinel lymph node biopsy. Our
group is amongst the very few supra-regional penile cancer
centres in the UK to routinely perform SPECT/CT in patients
undergoing dynamic sentinel lymph node biopsy. From a sur-
gical perspective, SPEC/CT identified the expected nodal
yield on surgical exploration, which led to the modification
of the surgical procedure so that all the nodes identified on
SPEC/CTwere localized in the inguinal basin using a gamma
probe. It also helped to ensure that unnecessary explorations
due to spillage or misregistration artefacts or activity from the
tracer-avid pelvic nodes were not performed. Thus far, histo-
logical analysis has shown metastatic disease limited to the
sentinel nodes rather than the echelon nodes, based on a path-
ological analysis which allows detection within 2-μm slice
thickness.
We believe that such routine incorporation of SPECT/CT
into the imaging protocol when performing dynamic sentinel
lymph node biopsy in patients with penile cancer can further
improve the sensitivity and specificity for the detection of
involved occult lymph nodes, which are both around 90%
when using 99mTc-nanocolloid imaging and ultrasonography
preoperatively in conjunction with intraoperative use of patent
blue dye and a handheld gamma probe [18].
The dynamic and early planar images have been reported to
visualize the first draining lymph node in approximately 85%
of cases [19], and this was confirmed by the present study, in
Table 2 Contingency matrix of lymph node detection on SPECT/CT
vs. planar scintigraphy
SPECT/CT
Yes No Total – planar
Planar Yes 387 53b 440
No 80a 0
Total – SPECT 467
a Includes 27 tracer-avid nodes that were reclassified from the inguinal to
the pelvic drainage basin or vice versa on the basis of SPECT/CT findings
b Includes 17 instances of skin contamination and 36 instances of in-
transit lymphatic tract activity
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which dynamic and early static images enabled visualization in
84% of patients. By definition, the first lymph node(s) draining
directly from the injection site is classified as the sentinel node.
In the case of multiple visible nodes without visible afferent
lymphatics, the first node appearing in a basin is considered
to be the sentinel node. When there is non-visualization on
dynamic and early and delayed planar imaging, it is generally
accepted practice to continue to acquire delayed static images
for up to 4 h until a tracer-avid node becomes visible. If a tracer-
avid node has still not been visualized after 4 h, proceeding to
intraoperative gamma probe localization is recommended.
However, the experience in our cohort has demonstrated that
inclusion of SPECT/CT, with its better contrast and resolution,
enables convincing localization of tiny tracer-avid nodes that
are otherwise difficult to detect, and therefore has the potential
to obviate the need for further delayed static images (which
may continue up to 4 h post-injection). A recent publication
has addressed this issue in detail [20].
Similarly, 2-D planar lymphoscintigraphy has been found
to accurately predict the number of nodes in only 81% of the
basins, overlooking nodes that are superimposed and cannot
be separated from other nodes or from the injection site
Fig. 2 a Planar image showing
tracer uptake (red arrow)
resembling a lymph node in the
suprapubic region. b SPECT/CT
image demonstrates that the up-
take noted in a actually represents
contamination (red arrow)
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(Fig. 4) or lymphatic channels, and nodes that are beyond the
resolution of the planar images [21, 22]. This limitation was
again highlighted in the present study, in which 53 additional
nodes were detected using SPECT/CT. We attribute the im-
provement in detection accuracy with SPECT/CT to its to-
mography and ability to overcome the effects of the inadequa-
cies of planar techniques, along with the use of non-
standardized acquisition protocols.
Although the acquisition of SPECT/CT images increases
the time required for preoperative imaging, it has the key
advantage of being able to precisely localize sentinel lymph
nodes for removal by the surgeon. The anatomical landmarks
for surgeons mainly relate to the depth of the node and the
proximity to the femoral vein and femoral canal, in addition to
the differentiation between nodes in the inguinal and pelvic
regions. This is not obvious on planar scanning, but is better
visualized on SPECT/CT, enabling planning of the procedure,
particularly in patients with a high BMI, when the nodes are
located deep in the inguinal region and gamma probe activity
is detected over a wider area.
The acquisition and correct interpretation of 3-D recon-
structive SPECT/CT preoperative images can reduce the time
Fig. 3 a Planar image shows at
least three tracer-avid foci (ma-
roon arrow) resembling lymph
nodes in the right groin. b
SPECT/CT images demonstrates
that one of the foci in a is essen-
tially an in-transit activity (ma-
roon arrow), potentially contrib-
uting to false-positive rates
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spent exploring the groins for the lymph nodes. Overall,
SPECT/CT offers a better detection rate than planar imaging,
or even intraoperative gamma probe detection on its own [23,
24]. Two separate studies have also demonstrated the cost-
effectiveness of using SPECT/CT in combination with planar
lymphoscintigraphy for the detection of sentinel lymph nodes
at complex sites [25, 26]. Common pitfalls in the interpreta-
tion of planar images are the localization of tracer-avid nodes
to the incorrect drainage basin and detection of false-positive
non-nodal sites of uptake due to scattering of radioactivity
from the injection site. In the present study, SPECT/CT led
to reclassification of 27 tracer-avid nodes from the inguinal to
the pelvic drainage basin or vice versa on the basis of anatom-
ical landmarks and compartments. It is important to mention
here that the technique was not primarily used to visualize
pelvic nodes, and these were not removed even if they were
tracer-avid. SPECT/CT ensured that unnecessary exploration
was not performed in cases where the planar imaging showed
the presence of inguinal nodes (which were subsequently
found to be located in the pelvis). Surgically, this resulted in
a reduction in the surgical operative time, limited the
dissection to the inguinal nodes, and reassured the surgeon
that residual gamma probe activity corresponded to activity
in the pelvic nodes or skin contamination.
An important prerequisite of intraoperative surgical
removal of the lymph nodes is the use of a gamma
probe. Therefore, the additional nodes on SPECT/CT
would likely have been detected if planar scans with
gamma probe activity were used, provided the surgeon
had ensured that the probe detected background radiation
at the end of the procedure. The study has demonstrated
that the addition of SPECT/CT allows for better surgical
planning so that the surgeon knows the expected nodal
yield from each groin and can account for the additional
gamma probe activity in cases of pelvic node radioiso-
tope uptake or spillage. This study also demonstrates that
SPECT/CT per se is adequate for the detection of the
sentinel node and echelon nodes, such that patients can
undergo a radioisotope injection followed by a 2-h
SPEC/CT. This provided the surgical team with ample
imaging data to explore the inguinal region and remove
the relevant nodes.
This study also confirmed the consistent and stepwise
lymphatic drainage which occurs in penile cancer, first to
the inguinal and then to the pelvic basin; however, on
SPECT/CT, we also noted a solitary node which escaped
the usual pattern of drainage and was located at an unusu-
al site (mid-thigh) (Fig. 5).
The main limitation of our study was having a con-
ceptual agreement when the true sentinel node was not
visualized at the end of dynamic imaging, and referring
to the subsequently appearing node(s) at delayed time
points as tracer-avid nodes which would have a high
probability of being the sentinel node. It is evident from
our study that SPECT/CT does not serve to replace pla-
nar lymphoscintigraphy, especially the dynamic compo-
nent, which is still the gold standard for identification of
the sentinel lymph node.
Another limitation that we observed was that al-
though SPECT/CT could identify the nodes in the in-
guinal basin, it could not differentiate or predict which
specific node would harbour metastatic disease, as the
most important prognostic indicator for patients with
penile cancer is the presence of metastatic disease in
the inguinal lymph nodes. Currently, the additional
lymph nodes may not be significant in terms of the
detection of micro-metastatic disease histologically;
however, it did provide reassurance that the lymph
nodes draining the penis which may harbour micro-
metastatic disease have all been removed. As the central
focus of the current article was SPECT/CT imaging, and
follow-up data for most of the patients in this cohort
with regard to surgical and histopathological findings
are still under evaluation, the correlative aspect between
Fig. 4 SPECT/CT clearly localizes a node (red arrows) that was missed
on planar imaging due to adjacent intense activity
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imaging results, surgery, and histopathological results
was not specifically addressed.
This study has demonstrated that the use of SPECT/
CT in conjunction with planar imaging offers numerous
advantages, i.e., detection of false positives due to con-
tamination and false negatives due to missed nodes on
2D planar imaging, more accurate localization of the
drainage basin and region, detection of lymphatic tract
leaks, identification of lymph nodes lying too close to
the injection site for detection on planar scintigraphy,
identification of sentinel nodes having little radioactivi-
ty, longer in-transit activity in the channels, and distinc-
tion between two nodes that lie close to each other and
therefore appear as a single node on planar scintigraphy.
Conclusions
Although this was a preliminary study, it is one of the
few in the literature with more than 100 patients which
has shown that the addition of SPECT/CT proved to be
significant—76% in our patient cohort. Our findings
demonstrate the inherent ability of SPECT/CT to pro-
vide superior images with increased nodal yield, more
precise localization, a clearer distribution and drainage
pattern, and a significant reduction in false extranodal
hot spots observed on conventional planar imaging.
Incorporating SPECT/CT can also deliver significant
time efficiency gains, as it has the potential to replace
static images (early and delayed) as well as the need for
skin marking. The study has confirmed the advantages
of SPECT/CT with respect to surgical planning and ac-
curacy of lymph node detection, and we recommend its
incorporated into the preoperative imaging protocol.
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